Logo
  • Home
  • About Us
    • Company
    • Leadership
    • Board of Directors
    • Board of Advisors
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us
  • Invest Via OurCrowd

  • Home /
  • News & Media
    • 24 Jun 2019

    Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors

    • Posted by:
    • HIL Applied Medical
    • No comments

    Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases of basic research, product development, engineering, commercialization and senior management. During the past 15 years …

    Continue reading »
    • 18 Apr 2019

    HIL and CERN enter collaboration (and Globes coverage)

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size and cost of Proton Therapy systems and achieve HIL’s goal of making this important treatment …

    Continue reading »
    • 17 Mar 2019

    HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set up a new R&D and manufacturing center on a 700 square-meter space leased from the …

    Continue reading »
    • 17 Mar 2019

    HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and Vetek association’s 2019 report on the Longevity Industry in Israel. The report is part of …

    Continue reading »
    • 07 Mar 2019

    HIL CEO and Dr. Morry Blumenfeld live on TV, at OurCrowd’s Global Investor Summit

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL CEO and Dr. Morry Blumenfeld live on TV, at OurCrowd’s Global Investor Summit HIL’s CEO Mr. Sagi Brink-Danan, and Dr. Morry Blumenfeld, Venture Partner and Chairman of the Medical Advisory Board at OurCrowd, participated in a discussion livestreamed from …

    Continue reading »
    • 06 Mar 2019

    HIL makes cover of The Marker Bio Magazine on International Women’s Day

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL makes cover of The Marker Bio Magazine on International Women’s Day HIL is featured in the cover story of The Marker’s Bio Magzine’s special edition for International Women’s Day. The issue is dedicated to the subject of Women’s Health, …

    Continue reading »
    • 10 Feb 2019

    Dr. Raphaël Van Roermund joins HIL’s R&D team

    • Posted by:
    • HIL Applied Medical
    • No comments

    Dr. Raphaël Van Roermund joins HIL’s R&D team Dr. Van Roermund, holding a PhD in quantum physics, is an expert in proton beam transport, dose delivery systems and dosimetry. Raphael comes to HIL following 8 years at IBA, the world …

    Continue reading »
    • 10 Dec 2018

    HIL to Participate in IIA’s China Roadshow

    • Posted by:
    • HIL Applied Medical
    • No comments

    HIL to Participate in IIA’s China Roadshow HIL was invited to partake in Israel Innovation Authority’s (IIA) and Israeli Export Institution’s delegation to China, in affiliation with CSTEC (China Science and Technology Exchange Center). Following a multi-stage competitive process – …

    Continue reading »
    • 02 Oct 2018

    The Nobel Prize in Physics, and an interview with HIL’s Founder & CTO Prof. Zigler

    • Posted by:
    • HIL Applied Medical
    • No comments

    The Nobel Prize in Physics, and an interview with HIL’s Founder & CTO Prof. Zigler This year’s Nobel Physics Prize was awarded in part to Gérard Mourou and Donna Strickland – developers of the revolutionary CPA (Chirped Pulse Amplification) technique, a …

    Continue reading »
    • 01 Oct 2018

    Dr. Moti Botton-Dascal of the Hebrew University of Jerusalem joins HIL’s R&D team

    • Posted by:
    • HIL Applied Medical
    • No comments

    Dr. Moti Botton-Dascal of the Hebrew University of Jerusalem joins HIL’s R&D team Dr. Botton-Dascal is a theoretician in plasma physics specialising in the interaction between radiation and matter. He has over 30 years’ experience in developing models and sophisticated …

    Continue reading »
      • «
      • 1
      • 2
      • 3
      • 4
      • 5
      • …
      • 8
      • »

Copyright 2010-2017 HIL Applied Medical (C) All rights reserved.
Design by Romi-G | Code by Digital Guru

  • Home
  • About Us
  • Proton Therapy
  • Technology
  • News & Media
  • Careers
  • Contact Us